E

KORU Medical Systems, Inc. KRMD

$3.23 $0.144.53% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.00$3.25
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

KRMD Rating

Reward
Risk

KRMD Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

KRMD Company Overview

KORU Medical Systems, Inc. is a U.S.-based medical technology company focused on the development, manufacture, and commercialization of infusion solutions for subcutaneous drug delivery. The company operates within the broader healthcare and medical device industries, with a primary emphasis on specialty infusion therapy. KORU’s products are designed to facilitate the administration of biologic medications and immune globulin therapies in home-based and ambulatory care settings. The company’s core revenue drivers include its infusion pump systems, consumable infusion sets, and related accessories used in chronic therapy treatments.

KORU’s primary platform is its wearable and portable subcutaneous infusion technology, including the FREEDOM infusion system product line. The company serves pharmaceutical manufacturers, specialty pharmacies, home infusion providers, hospitals, and patients requiring long-term infusion therapy. KORU has positioned itself around the growing trend toward home-based care and patient self-administration, particularly for chronic immune deficiencies and neurological conditions treated with subcutaneous immunoglobulin (SCIg). Originally founded as Repro-Med Systems, Inc., the company later rebranded to KORU Medical Systems to reflect its broader strategic focus on patient-centric infusion technologies and pharmaceutical partnerships.

Data compiled by narrative technology. May contain errors.
Sector

KRMD Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

KRMD Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

KRMD Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

KRMD Price History

Loading...
52-Week Range10% of range
Current
$3.23
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

KRMD Valuation

Market Cap
Market Cap Rank
#10,382
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

KRMD Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

KRMD Corporate Info

Phone Number
845 469 2042
Address
100 Corporate Drive
Mahwah, NJ 07430
Country
Year Founded

KRMD Filings

Filing Date
Wednesday, August 5, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

KRMD Headlines

11/9/2026 - SeekingAlpha.com: All News